Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. Malawi will begin broad use of RTS,S, Africa's first malaria vaccine for children under age five. The rollout follows completion of the PATH-assisted pilot implementation.
    Published: October 2022
  2. In this piece about a PATH-led, 50-district study on the feasibility of HIV self-testing, PATH’s Dr. Asha Hegde is quoted on the kit’s potential impact for reaching individuals who are unable to go for regular facility-based testing.
    Published: October 2022
  3. In this blog post, PATH’s Allen Namagembe and Dr. Jane Cover explain their team’s recent studies and how they used a human-centered design approach to develop and pilot self-injection in Uganda.
    Published: September 2022
  4. This piece highlights PATH Chief Scientific Officer, Dr. David Kaslow's appointment to director of the Office of Vaccines Research and Review at the US Food and Drug Administration.
    Published: September 2022

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

970 Item s
970 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release